Profile
| Metric | Value |
|---|---|
| Full Name | Cognition Therapeutics, Inc. |
| Ticker | NASDAQ: CGTX |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | cogrx.com |
| Employees | 25 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| $1.06 | ||
| Price, 1D Change | +6.03% | |
| $94M | ||
| - | ||
| - | ||
| 1.58 | ||
| $0 | ||
| Revenue, 1Y Change | 0.00% | |
| -$0.86 | ||
| EPS, 1Y Change | +0.44% |
Chart
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$0.86 | ||
| EPS Estimate | N/A | -$0.39 |
| EPS Est. Change | N/A | +54.39% |
| $0.00 | ||
| Revenue Estimate | N/A | - |
| Revenue Est. Change | N/A | - |
| $1.06 | ||
| Price Target | - | $3.50 |
| Price Tgt. Change | - | +230.19% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$0.95 | -$0.86 | +9.60% | |
| -$0.79 | -$0.86 | -8.92% | |
| -$0.39 | N/A | +54.39% | |
| -$0.34 | N/A | +60.82% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | $0.00 | - | |
| - | N/A | - | |
| - | N/A | - |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| +65.62% | ||
| -46.46% | ||
| +144.26% | ||
| +63.01% | ||
| 0.00% | ||
| 0.00% | ||
| +0.44% | ||
| -16.98% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| $1.06 | ||
| $1.20 | ||
| SMA 200 vs Price | +13.07% | |
| $1.45 | ||
| SMA 50 vs Price | +36.87% | |
| 1.58 | ||
| $0.10 | ||
| 34.23 | ||
| 89.74% | ||
| 137.24% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $0.00 | ||
| -$0.86 | ||
| -$266.00K | ||
| - | ||
| -$34.42M | ||
| - | ||
| -$33.97M | ||
| - | ||
| -$33.68M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.03 | ||
| 2.65 | ||
| 2.65 | ||
| -1,357.84 | ||
| - | ||
| -6.20 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| 2.56 | ||
| -1.21 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $18.75M | ||
| $25.01M | ||
| $30.23M | ||
| $29.56M | ||
| $11.48M | ||
| $11.14M | ||
| $535.00K | ||
| $193.00K | ||
| $1.98M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $34.42M | ||
| $34.42M | ||
| $266.00K | ||
| $12.29M | ||
| $266.00K | ||
| $25.00K | ||
| $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$28.47M | ||
| -$4,000.00 | ||
| $23.57M | ||
| $4,000.00 | ||
| -$28.48M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| HC Wainwright & Co. | → | |
| B. Riley Securities | → | |
| HC Wainwright & Co. | → | |
| Chardan Capital | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| Chardan Capital | → | |
| HC Wainwright & Co. | → | |
| Chardan Capital | → | |
| Chardan Capital | → |
Analyst sentiment
Institutional ownership
Screeners with CGTX
FAQ
What is the ticker symbol for Cognition Therapeutics, Inc.?
The ticker symbol for Cognition Therapeutics, Inc. is NASDAQ:CGTX
Does Cognition Therapeutics, Inc. pay dividends?
No, Cognition Therapeutics, Inc. does not pay dividends
What sector is Cognition Therapeutics, Inc. in?
Cognition Therapeutics, Inc. is in the Healthcare sector
What industry is Cognition Therapeutics, Inc. in?
Cognition Therapeutics, Inc. is in the Biotechnology industry
What country is Cognition Therapeutics, Inc. based in?
Cognition Therapeutics, Inc. is headquartered in United States
When did Cognition Therapeutics, Inc. go public?
Cognition Therapeutics, Inc. initial public offering (IPO) was on October 8, 2021
Is Cognition Therapeutics, Inc. in the S&P 500?
No, Cognition Therapeutics, Inc. is not included in the S&P 500 index
Is Cognition Therapeutics, Inc. in the NASDAQ 100?
No, Cognition Therapeutics, Inc. is not included in the NASDAQ 100 index
Is Cognition Therapeutics, Inc. in the Dow Jones?
No, Cognition Therapeutics, Inc. is not included in the Dow Jones index
When was Cognition Therapeutics, Inc. last earnings report?
Cognition Therapeutics, Inc.'s most recent earnings report was on November 12, 2025
When does Cognition Therapeutics, Inc. report earnings?
The date for Cognition Therapeutics, Inc.'s next earnings report has not been announced yet
Data Sources & References
- CGTX Official Website www.cogrx.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1455365/000110465925107402/0001104659-25-107402-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1455365/000155837025003341/0001558370-25-003341-index.htm
- CGTX Profile on Yahoo Finance finance.yahoo.com/quote/CGTX
- CGTX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/cgtx